Agomelatine: An antidepressant with new potent hepatoprotective effects on paracetamol-induced liver damage in rats

Human and Experimental Toxicology

Volumn 32, Issue 8, 2013, Pages 846-857

  Karakus, E ^a   Halici, Z ^b   Albayrak, A ^b   Polat, B ^a   Bayir, Y ^a   Kiki, I ^b   Cadirci, E ^a   Topcu, A ^b   Aksak, S ^b  

^a ATATÜRK UNIVERSITY   (Turkey)

^b ATATURK UNIVERSITY   (Turkey)

Author keywords

8 iso prostaglandin F2 ; Agomelatine; hepatotoxicity; IL 6; paracetamol; TNF

Indexed keywords

8 ISOPROSTANE; ACETYLCYSTEINE; AGOMELATINE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GLUTATHIONE; INTERLEUKIN 6; PARACETAMOL; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; HISTOPATHOLOGY; LIVER INJURY; LIVER TOXICITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT;

8-ISO-PROSTAGLANDIN F2Α; AGOMELATINE; HEPATOTOXICITY; IL-6; PARACETAMOL; TNF-Α;

ACETAMIDES; ACETAMINOPHEN; ALANINE TRANSAMINASE; ANIMALS; ANTIDEPRESSIVE AGENTS; ASPARTATE AMINOTRANSFERASES; DINOPROST; DRUG-INDUCED LIVER INJURY; GLUTATHIONE; INTERLEUKIN-6; LIVER; MALE; PROTECTIVE AGENTS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 84879755689     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327112472994     Document Type: Article

References (51)

1. Gregory SH, Wing EJ. Neutrophil-Kupffer-cell interaction in host defenses to systemic infections. Immunol Today. 1998 ; 19: 507-510
2. Nagy LE. Recent insights into the role of the innate immune system in the development of alcoholic liver disease. Exp Biol Med (Maywood). 2003 ; 228: 882-890
3. Sweet MJ, Hume DA. Endotoxin signal transduction in macrophages. J Leukoc Biol. 1996 ; 60: 8-26
4. Blazka ME, Wilmer JL, Holladay SD, Wilson RE, Luster MI. Role of proinflammatory cytokines in acetaminophen hepatotoxicity. Toxicol Appl Pharmacol. 1995 ; 133: 43-52
5. Laskin DL, Pilaro AM.. Potential role of activated macrophages in acetaminophen hepatotoxicity. I. Isolation and characterization of activated macrophages from rat liver. Toxicol Appl Pharmacol. 1986 ; 86: 204-215
6. Jones R.. Nonsteroidal anti-inflammatory drug prescribing: past, present, and future. Am J Med. 2001 ; 110 (1A). 4s-/S
7. Hawkins N, Golding J. A. survey of the administration of drugs to young infants. The alspac survey team. Avon longitudinal study of pregnancy and childhood. Br J Clin Pharmacol. 1995 ; 40: 79-82
8. Chattopadhyay RR. Possible mechanism of hepatoprotective activity of Azadirachta indica leaf extract: part II. J Ethnopharmacol. 2003 ; 89: 217-219
9. Lewis RK, Paloucek FP. Assessment and treatment of acetaminophen overdose. Clin Pharm. 1991 ; 10: 765-774
10. Prescott LF.. Paracetamol overdosage. Pharmacological considerations and clinical management. Drugs. 1983 ; 25: 290-314
11. Davidson DG, Eastham WN. Acute liver necrosis following overdose of paracetamol. Br Med J. 1966 ; 2: 497-499
12. Brok J, Buckley N, Gluud C.. Interventions for paracetamol (acetaminophen) overdose. Cochrane Database Syst Rev. 2006 ; 2: CD003328
13. Larson AM. Acetaminophen hepatotoxicity. Clin Liver Dis. 2007 ; 11: 525-48
14. Makin AJ, Wendon J, Williams R. A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987-1993). Gastroenterol. 1995 ; 109: 1907-1916
15. El-Ridi MR, Rahmy TR. Action of vitamin C against acetaminophen-induced hepatorenal toxicity in rats. J Toxicol-Toxin Rev. 2000 ; 19: 275-304
16. Ajith TA, Hema U, Aswathy MS. Zingiber officinale Roscoe prevents acetaminophen-induced acute hepatotoxicity by enhancing hepatic antioxidant status. Food Chem Toxicol. 2007 ; 45: 2267-2272
17. Depreux P, Lesieur D, Mansour HA, et al. Synthesis and structure-activity relationships of novel naphthalenic and bioisosteric related amidic derivatives as melatonin receptor ligands. J Med Chem. 1994 ; 37: 3231-3239
18. Krauchi K, Cajochen C, Mori D, et al. Early evening melatonin and S-20098 advance circadian phase and nocturnal regulation of core body temperature. Am J Physiol. 1997 ; 272: R1178 - R1188
19. Lemoine P, Guilleminault C, Alvarez E. Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: randomized, double-blind comparison with venlafaxine. J Clin Psychiatr. 2007 ; 68: 1723-1732
20. Quera Salva MA, Vanier B, Laredo J, et al. Major depressive disorder, sleep EEG and agomelatine: an open-label study. Int J Neuropsychopharmacol. 2007 ; 10: 691-696
21. Reiter RJ. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocrine Rev. 1991 ; 12: 151-180
22. Matsura T, Nishida T, Togawa A, et al. Mechanisms of protection by melatonin against acetaminophen-induced liver injury in mice. J Pineal Res. 2006 ; 41: 211-219
23. Corcoran GB, Mitchell JR, Vaishnav YN, et al. Evidence that acetaminophen and N-hydroxyacetaminophen form a common arylating intermediate, N-acetyl-p-benzoquinoneimine. Mol Pharmacol. 1980 ; 18: 536-542
24. Bessems JG, Vermeulen NP. Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches. Crit Rev Toxicol. 2001 ; 31: 55-138
25. Ojo OO, Kabutu FR, Bello M, Babayo U. Inhibition of paracetamol-induced oxidative stress in rats by extracts of lemongrass (Cymbropogon citratus) and green tea (Camellia sinensis) in rats. Afr J Biotechnol. 2006 ; 5: 1227-1232
26. Rajasekaran A, Periyasamy M. Hepatoprotective effect of ethanolic extract of Trichosanthes lobata on paracetamol-induced liver toxicity in rats. Chinese Med. 2012 ;: 7 12
27. Yamanaka K, Hasegawa A, Sawamura R, Okada S.. Cellular response to oxidative damage in lung induced by the administration of dimethylarsinic acid, a major metabolite of inorganic arsenics, in mice. Toxicol Appl Pharmacol. 1991 ; 108: 205-213
28. Dai Y, Cederbaum AI. Cytotoxicity of acetaminophen in human cytochrome P4502E1-transfected HepG2 cells. J Pharmacol Exp Therapeut. 1995 ; 273: 1497-1505
29. Samokyszyn VM, Thomas CE, Reif DW, Saito M, Aust SD. Release of iron from ferritin and its role in oxygen radical toxicities. Drug Metabol Rev. 1988 ; 19: 283-303
30. Sakamoto M, Takaki E, Yamashita K, et al. Nonenzymatic derived lipid peroxide, 8-iso-PGF2 alpha, participates in the pathogenesis of delayed cerebral vasospasm in a canine SAH model. Neurol Res. 2002 ; 24: 301-306
31. Basu S, Hellberg A, Ulus AT, et al. Biomarkers of free radical injury during spinal cord ischemia. FEBS Lett. 2001 ; 508: 36-38
32. Jaeschke H, Bajt ML. Intracellular signaling mechanisms of acetaminophen-induced liver cell death. Toxicol Sci. 2006 ; 89: 31-41
33. Dolder CR, Nelson M, Snider M. Agomelatine treatment of major depressive disorder. Annal Pharmacother. 2008 ; 42: 1822-1831
34. Millan MJ, Gobert A, Lejeune F, et al. The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways. J Pharmacol Exp Therapeut. 2003 ; 306: 954-964
35. Guerrero JM, Reiter RJ. Melatonin-immune system relationships. Curr Top Med Chem. 2002 ; 2: 167-179
36. Cos S, Fernandez R, Guezmes A, Sanchez-Barcelo EJ. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. Canc Res. 1998 ; 58: 4383-4390
37. Reiter RJ. The ageing pineal gland and its physiological consequences. Bioessays. 1992 ; 14: 169-175
38. Reiter RJ. Oxidative damage in the central nervous system: protection by melatonin. Progr Neurobiol. 1998 ; 56: 359-384
39. Dubocovich ML. Melatonin receptors: are there multiple subtypes?. Trend Pharmacol Sci. 1995 ; 16: 50-56
40. Wiesenberg I, Missbach M, Kahlen JP, Schrader M, Carlberg C. Transcriptional activation of the nuclear receptor RZR alpha by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand. Nucleic Acid Res. 1995 ; 23: 327-333
41. Benitez-King G, Huerto-Delgadillo L, Anton-Tay F. Binding of 3H-melatonin to calmodulin. Life Sci. 1993 ; 53: 201-207
42. Reiter RJ. Antioxidant actions of melatonin. Adv Pharmacol. 1997 ; 38: 103-117
43. Sener G, Sehirli AO, Ayanoglu-Dulger G. Protective effects of melatonin, vitamin E and N-acetylcysteine against acetaminophen toxicity in mice: a comparative study. J Pineal Res. 2003 ; 35: 61-68
44. Urata Y, Honma S, Goto S, et al. Melatonin induces gamma-glutamylcysteine synthetase mediated by activator protein-1 in human vascular endothelial cells. Free Rad Biol Med. 1999 ; 27: 838-847
45. Kanno S, Tomizawa A, Hiura T, et al. Melatonin protects on toxicity by acetaminophen but not on pharmacological effects in mice. Biol Pharmaceut Bullet. 2006 ; 29: 472-476
46. Kaushal R, Dave KR, Katyare SS. Paracetamol hepatotoxicity and microsomal function. Environ Toxicol Pharmacol. 1999 ; 7: 67-74
47. Pierce RH, Campbell JS, Stephenson AB, et al. Disruption of redox homeostasis in tumor necrosis factor-induced apoptosis in a murine hepatocyte cell line. Am J Pathol. 2000 ; 157: 221-236
48. Nagai H, Matsumaru K, Feng G, Kaplowitz N. Reduced glutathione depletion causes necrosis and sensitization to tumor necrosis factor-alpha-induced apoptosis in cultured mouse hepatocytes. Hepatol. 2002 ; 36: 55-64
49. James LP, McCullough SS, Lamps LW, Hinson JA. Effect of N-acetylcysteine on acetaminophen toxicity in mice: relationship to reactive nitrogen and cytokine formation. Toxicol Sci. 2003 ; 75: 458-467
50. Hinson JA, Pohl LR, Monks TJ, Gillette JR, Guengerich FP. 3-Hydroxyacetaminophen: a microsomal metabolite of acetaminophen. Evidence against an epoxide as the reactive metabolite of acetaminophen. Drug Metab Dispos. 1980 ; 8: 289-294
51. Chun LJ, Tong MJ, Busuttil RW, Hiatt JR. Acetaminophen hepatotoxicity and acute liver failure. J Clin Gastroenterol. 2009 ; 43: 342-349